Evidence map›Paper›PMID 39024367›Full record

ArticlePloS one2024

Preparation and application of an economical and environmentally friendly hydrate inhibitor in gas field development.

Dong Liao, Gui Su, Lei Liang, Jian He, Haifeng Ye, Qinghua Xiao, Yujia Xiong, Dong Wang, Lang Liu, Xingyu Luo

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dong LiaoCCDC Geological Exploration and Development Research Institute, Chengdu, China.
Gui SuSichuan Hengyi Petroleum Technology Service Co. Ltd., Chengdu, China.
Lei LiangCCDC Geological Exploration and Development Research Institute, Chengdu, China.ORCID 0000-0001-5655-5126
Jian HeCCDC Geological Exploration and Development Research Institute, Chengdu, China.
Haifeng YeCCDC Geological Exploration and Development Research Institute, Chengdu, China.
Qinghua XiaoCCDC Geological Exploration and Development Research Institute, Chengdu, China.
Yujia XiongCCDC Geological Exploration and Development Research Institute, Chengdu, China.
Dong WangCCDC Geological Exploration and Development Research Institute, Chengdu, China.
Lang LiuCCDC Geological Exploration and Development Research Institute, Chengdu, China.
Xingyu LuoCCDC Geological Exploration and Development Research Institute, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevention and control of natural gas hydrates is an important link in ensuring winter production. Traditional thermodynamic inhibitors, like methanol, are commonly utilized due to their low unit costs and pricing, but they come with considerable safety issues when used on-site due to their high toxicity, flammability, and explosive potential. A cost-effective and eco-friendly hydrate inhibitor was created by combining light polyol amine with other ingredients to solve this problem. At a concentration of 30%, the product has a flash point greater than 80°C and a solidification point of -45°C. With success rates of 99% and 100%, respectively, it was used for winter casing pre-injection anti-freezing operations and balancing tank defoamer anti-freezing operations. Experiments have demonstrated the effectiveness of this inhibitor in preventing the formation of natural gas hydrates. In wintertime on-site anti-freezing activities, the projected cost can be substituted for methanol, as it is essentially equivalent to methanol.

Indexed as

Natural GasSeasonsThermodynamicsWaterNatural GasWater

Identifiers

PMID39024367
PMCPMC11257235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.